Pelicare Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-07-2024
- Paid Up Capital ₹ 1.00 M
as on 09-07-2024
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit -42.14%
(FY 2022)
- Ebitda -395.49%
(FY 2022)
- Net Worth -16.87%
(FY 2022)
- Total Assets 249.52%
(FY 2022)
About Pelicare Lifescience
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Dhabalia, Vijaybhai Shrimanker, and Bharat Shrimanker serve as directors at the Company.
- CIN/LLPIN
U24299GJ2020PTC117553
- Company No.
117553
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Oct 2020
- Date of AGM
20 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Jamnagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Pelicare Lifescience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Dhabalia  | Director | 21-Oct-2020 | Current |
| Vijaybhai Shrimanker | Nominee Director | 21-Oct-2020 | Current |
| Bharat Shrimanker | Nominee Director | 21-Oct-2020 | Current |
Financial Performance of Pelicare Lifescience.
Pelicare Lifescience Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 42.14% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pelicare Lifescience?
Unlock access to Pelicare Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Accurate Moto (Gujarat) Private LimitedActive 12 years 10 monthsVijaybhai Shrimanker is a mutual person
Pelican Rotoflex Private LimitedActive 28 yearsVijaybhai Shrimanker and Bharat Shrimanker are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pelicare Lifescience?
Pelicare Lifescience has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pelicare Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pelicare Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
